CN110522833A - A kind of production method of frost - Google Patents

A kind of production method of frost Download PDF

Info

Publication number
CN110522833A
CN110522833A CN201810515997.2A CN201810515997A CN110522833A CN 110522833 A CN110522833 A CN 110522833A CN 201810515997 A CN201810515997 A CN 201810515997A CN 110522833 A CN110522833 A CN 110522833A
Authority
CN
China
Prior art keywords
extract
cetostearyl alcohol
replaced
oil
frost
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201810515997.2A
Other languages
Chinese (zh)
Inventor
李哪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201810515997.2A priority Critical patent/CN110522833A/en
Publication of CN110522833A publication Critical patent/CN110522833A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a kind of production methods of frost, including water, butanediol, glycerol, allantoin, Sodium Hyaluronate, cetostearyl alcohol olive oleate, cetostearyl alcohol, isohexadecane, Parleam, Butyrospermum parkii oil, tridecanol stearate, caprylic/capric triglyceride, first dimethyl silicone polymer, tocopherol acetate, olive oil, Nipasol, second dimethyl silicone polymer, polyacrylamide, ginseng root extract, promote to seep the factor, bulk kelp extract, hamamelis extract, essence, methylisothiazolinone, purslane extract and aloe extract.The present invention provides a kind of production method of frost, the various toxin generated in people's body is effectively removed through diet by the red ginseng frost of batch production, to reach prevention three height, diabetes, all kinds of cancers.

Description

A kind of production method of frost
Technical field
The present invention relates to a kind of omnipotent frost more particularly to a kind of production methods of frost.
Background technique
In daily life, various bad habits and environmental pollution, cause in actual life, middle-aged and the old's various diseases are high Hair, especially three height, diabetes, all kinds of cancers, with the increasingly improvement that people live, the disease incidence of these illnesss can be higher.
Summary of the invention
The object of the invention is that providing a kind of production method of frost to solve the above-mentioned problems.
The present invention through the following technical solutions to achieve the above objectives:
The present invention includes water, butanediol, glycerol, allantoin, Sodium Hyaluronate, cetostearyl alcohol olive oleate, cetearyl alcohol Alcohol, isohexadecane, Parleam, Butyrospermum parkii oil, tridecanol stearate, caprylic/capric triglyceride, first gather Dimethyl siloxane, tocopherol acetate, olive oil, Nipasol, the second dimethyl silicone polymer, polyacrylamide, Ginseng root extract promotees to seep the factor, bulk kelp extract, hamamelis extract, essence, methylisothiazolinone, purslane Extract and aloe extract are weighed various raw materials with certain proportion, are made with following steps:
Step 1: water is added in the water, the butanediol, the glycerol, the allantoin and the Sodium Hyaluronate by water phase Pot, is heated to 80 degree；
Step 2: oily phase, by the cetostearyl alcohol olive oleate, the cetostearyl alcohol, the isohexadecane, the hydrogen Change polyisobutene, Butyrospermum parkii oil, the tridecanol stearate, the caprylic/capric triglyceride, described first Oil cauldron is added in dimethyl silicone polymer, the tocopherol acetate, the olive oil and the Nipasol, is heated to 80 Degree；
Step 3: by it is described oil mutually be pumped into preheating emulsion pot in, open stirring, after by the water phase be pumped into emulsion pot in homogeneous 5 minutes, it is cooled to 70 degree of addition second dimethyl silicone polymers and the polyacrylamide, homogeneous 5 minutes, continues to cool down To 45 degree be added the ginseng root extract, the rushs infiltration factor, the bulk kelp extract, the hamamelis extract, The essence, the methylisothiazolinone, the purslane extract and the aloe extract, stir evenly, and examine and close It discharges, is put in storage through filling, packaging, after the assay was approved after lattice within standing 24 hours.
Preferably, the cetostearyl alcohol olive oleate can be replaced the present invention by the smooth olive oleate of sorb, the whale Wax stearyl alcohol can be replaced by cetearyl glucoside, and second dimethyl silicone polymer can be by dimethiconol generation It replaces, the methylisothiazolinone can be replaced by Sensiva SC50.
Preferably, the composition specific gravity of the water is 63.08% to the present invention, the composition specific gravity of the butanediol is 9%, described sweet The composition specific gravity of oil is 2%, the composition specific gravity of the allantoin is 0.2%, the composition specific gravity of the Sodium Hyaluronate is 0.02%, The composition specific gravity of the cetostearyl alcohol olive oleate is 2%, the composition specific gravity of the cetostearyl alcohol is 2%, described different ten The composition specific gravity of six alkane is 4%, the composition specific gravity of the Parleam is 3%, the composition specific gravity of Butyrospermum parkii oil is 2%, the composition specific gravity of the tridecanol stearate is 2%, the composition specific gravity of the caprylic/capric triglyceride is 3%, institute The composition specific gravity for stating the first dimethyl silicone polymer is 3%, the composition specific gravity of the tocopherol acetate is 0.2%, the oily olive The composition specific gravity of olive fruit oil is 1.5%, the composition specific gravity of the Nipasol is 0.2%, second dimethyl silicone polymer Composition specific gravity is 0.5%, the composition specific gravity of the polyacrylamide is 0.7%, the composition specific gravity of the ginseng root extract is 0.1%, the composition specific gravity for promoting the infiltration factor is 0.5%, the composition specific gravity of the bulk kelp extract is 0.5%, North America gold thread The composition specific gravity of prunus mume extract is 0.1%, the composition specific gravity of the essence is 0.1%, the composition ratio of the methylisothiazolinone Weight is 0.1%, the composition specific gravity of the purslane extract is 0.5% and the composition specific gravity of the aloe extract is 0.5%.
The beneficial effects of the present invention are:
The present invention provides a kind of production method of frost, is effectively removed in people's body through diet by the red ginseng frost of batch production The various toxin generated, to reach prevention three height, diabetes, all kinds of cancers.
Detailed description of the invention
Fig. 1 is a kind of structural schematic diagram of the production method of frost of the present invention.
Specific embodiment
The present invention will be further explained below with reference to the attached drawings:
The present invention includes water, butanediol, glycerol, allantoin, Sodium Hyaluronate, cetostearyl alcohol olive oleic acid as shown in Figure 1: Ester, cetostearyl alcohol, isohexadecane, Parleam, Butyrospermum parkii oil, tridecanol stearate, caprylic/capric glycerol Three esters, the first dimethyl silicone polymer, tocopherol acetate, olive oil, Nipasol, the second dimethyl silicone polymer, Polyacrylamide, ginseng root extract promote to seep the factor, bulk kelp extract, hamamelis extract, essence, methyl-isothiazol Quinoline ketone, purslane extract and aloe extract are weighed various raw materials with certain proportion, are made with following steps:
Step 1: water is added in the water, the butanediol, the glycerol, the allantoin and the Sodium Hyaluronate by water phase Pot, is heated to 80 degree；
Step 2: oily phase, by the cetostearyl alcohol olive oleate, the cetostearyl alcohol, the isohexadecane, the hydrogen Change polyisobutene, Butyrospermum parkii oil, the tridecanol stearate, the caprylic/capric triglyceride, described first Oil cauldron is added in dimethyl silicone polymer, the tocopherol acetate, the olive oil and the Nipasol, is heated to 80 Degree；
Step 3: by it is described oil mutually be pumped into preheating emulsion pot in, open stirring, after by the water phase be pumped into emulsion pot in homogeneous 5 minutes, it is cooled to 70 degree of addition second dimethyl silicone polymers and the polyacrylamide, homogeneous 5 minutes, continues to cool down To 45 degree be added the ginseng root extract, the rushs infiltration factor, the bulk kelp extract, the hamamelis extract, The essence, the methylisothiazolinone, the purslane extract and the aloe extract, stir evenly, and examine and close It discharges, is put in storage through filling, packaging, after the assay was approved after lattice within standing 24 hours.
The cetostearyl alcohol olive oleate can be replaced by the smooth olive oleate of sorb, and the cetostearyl alcohol can be by whale Wax stearyl glucoside replaces, and second dimethyl silicone polymer can be replaced by dimethiconol, and the methyl is different Thiazolinone can be replaced by Sensiva SC50.
The composition specific gravity of the water is 63.08%, the composition specific gravity of the butanediol is 9%, the composition specific gravity of the glycerol Composition specific gravity for the 2%, allantoin is 0.2%, the composition specific gravity of the Sodium Hyaluronate is 0.02%, the cetearyl alcohol The composition specific gravity of alcohol olive oleate is 2%, the composition specific gravity of the cetostearyl alcohol is 2%, the composition ratio of the isohexadecane Weight is 4%, the composition specific gravity of the Parleam is 3%, the composition specific gravity of Butyrospermum parkii oil is 2%, the tridecane The composition specific gravity of alcohol stearate is 2%, the composition specific gravity of the caprylic/capric triglyceride is 3%, first poly dimethyl The composition specific gravity of siloxanes is 3%, the composition specific gravity of the tocopherol acetate is 0.2%, the composition ratio of the olive oil Weight is 1.5%, the composition specific gravity of the Nipasol is 0.2%, the composition specific gravity of second dimethyl silicone polymer is 0.5%, The composition specific gravity of the polyacrylamide is 0.7%, the composition specific gravity of the ginseng root extract is 0.1%, the rush seeps the factor Composition specific gravity be 0.5%, the composition specific gravity of the bulk kelp extract is 0.5%, the composition ratio of the hamamelis extract Weight is 0.1%, the composition specific gravity of the essence is 0.1%, the composition specific gravity of the methylisothiazolinone is 0.1%, the dent The composition specific gravity of amaranth extract is 0.5% and the composition specific gravity of the aloe extract is 0.5%.
Those skilled in the art do not depart from essence and spirit of the invention, can there are many deformation scheme realize the present invention, The foregoing is merely preferably feasible embodiments of the invention, and not thereby limiting the scope of the invention, all with this The variation of equivalent structure made by description of the invention and accompanying drawing content, is intended to be included within the scope of the present invention.

Claims (3)

1. a kind of production method of frost, which is characterized in that hard including water, butanediol, glycerol, allantoin, Sodium Hyaluronate, spermaceti Lipidol olive oleate, cetostearyl alcohol, isohexadecane, Parleam, Butyrospermum parkii oil, tridecanol stearate, Caprylic/capric triglyceride, the first dimethyl silicone polymer, tocopherol acetate, olive oil, Nipasol, second gather Dimethyl siloxane, ginseng root extract, promotees to seep the factor, bulk kelp extract, hamamelis extract, perfume (or spice) polyacrylamide Essence, methylisothiazolinone, purslane extract and aloe extract weigh various raw materials with certain proportion, with following steps It is made:
Step 1: water is added in the water, the butanediol, the glycerol, the allantoin and the Sodium Hyaluronate by water phase Pot, is heated to 80 degree；
Step 2: oily phase, by the cetostearyl alcohol olive oleate, the cetostearyl alcohol, the isohexadecane, the hydrogen Change polyisobutene, Butyrospermum parkii oil, the tridecanol stearate, the caprylic/capric triglyceride, described first Oil cauldron is added in dimethyl silicone polymer, the tocopherol acetate, the olive oil and the Nipasol, is heated to 80 Degree；
Step 3: by it is described oil mutually be pumped into preheating emulsion pot in, open stirring, after by the water phase be pumped into emulsion pot in homogeneous 5 minutes, it is cooled to 70 degree of addition second dimethyl silicone polymers and the polyacrylamide, homogeneous 5 minutes, continues to cool down To 45 degree be added the ginseng root extract, the rushs infiltration factor, the bulk kelp extract, the hamamelis extract, The essence, the methylisothiazolinone, the purslane extract and the aloe extract, stir evenly, and examine and close It discharges, is put in storage through filling, packaging, after the assay was approved after lattice within standing 24 hours.
2. a kind of production method of frost according to claim 1, it is characterised in that: the cetostearyl alcohol olive oleate It can be replaced by the smooth olive oleate of sorb, the cetostearyl alcohol can be replaced by cetearyl glucoside, and described second poly- two Methylsiloxane can be replaced by dimethiconol, and the methylisothiazolinone can be replaced by Sensiva SC50.
3. a kind of production method of frost according to claim 1, it is characterised in that: the cetostearyl alcohol olive oleate It can be replaced by the smooth olive oleate of sorb, the cetostearyl alcohol can be replaced by cetearyl glucoside, and described second poly- two Methylsiloxane can be replaced by dimethiconol, and the methylisothiazolinone can be replaced by Sensiva SC50.
CN201810515997.2A 2018-05-26 2018-05-26 A kind of production method of frost Withdrawn CN110522833A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810515997.2A CN110522833A (en) 2018-05-26 2018-05-26 A kind of production method of frost

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810515997.2A CN110522833A (en) 2018-05-26 2018-05-26 A kind of production method of frost

Publications (1)

Publication Number Publication Date
CN110522833A true CN110522833A (en) 2019-12-03

Family

ID=68657733

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810515997.2A Withdrawn CN110522833A (en) 2018-05-26 2018-05-26 A kind of production method of frost

Country Status (1)

Country Link
CN (1) CN110522833A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112022777A (en) * 2020-10-22 2020-12-04 北京唯爱生物科技有限公司 Rosa roxburghii water replenishing fragment cream and preparation method and application thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112022777A (en) * 2020-10-22 2020-12-04 北京唯爱生物科技有限公司 Rosa roxburghii water replenishing fragment cream and preparation method and application thereof

Similar Documents

Publication Publication Date Title
CN107519224A (en) A kind of preparation method of red ginseng frost
CN107550764B (en) Preparation method of high-stability Plukenetia volubilis linneo oil-lubricated Q marble
CN110192985A (en) A kind of care agent and preparation method thereof for skin moisture-keeping reparation
CN110522833A (en) A kind of production method of frost
CN101433500A (en) Low-viscosity skin lotion and preparation method thereof
CN102793656B (en) Firming anti-wrinkle essence cosmetic and preparation method
CN109330965B (en) A cosmetic composition containing plant extract
CN103989619B (en) A kind of glossy ganoderma anti-aging face cream and preparation method thereof
CN107519051A (en) A kind of multifunctional beauty treatment cream and preparation method thereof
CN107375022A (en) A kind of skin care compositions for repairing sensitive skin
JP4265127B2 (en) Silver powder for silver clay excellent in low temperature sintering property and silver clay containing this silver powder
CN105030586B (en) A kind of whitening patch-lightening cosmetic of peptide containing marine active and preparation method thereof
CN106474016A (en) A kind of scalp topical composition and scalp tonic liquid
CN105997647A (en) Anti-aging eye cream containing artemisia selengensis extract and preparation method thereof
CN114831206A (en) Fishy smell-free and storage-resistant DHA algal oil plant-based gel candy and preparation method thereof
CN105943427B (en) A kind of multiple-effect containing peony seed oil moistens eye cream and preparation method thereof
CN107468610A (en) A kind of extraction product of rice bran shell and its application in facial-care
Montserrat-de la Paz et al. Olive oil, compared to a saturated dietary fat, has a protective role on atherosclerosis in niacin-treated mice with metabolic syndrome
CN108785196A (en) A kind of composition for smoothing acne hole acne print and its application in cosmetics
CN115487092A (en) Isolation sunscreen cream and preparation method thereof
ZULMI et al. Incorporation Vitamin E From Pfad In Matrix Of Mixed Galaktomanan Kolang-Kaling (Arenga Pinnata) And Gum Acasia
CN111616968B (en) Composition for Guifu ointment and preparation method, use method and application thereof
CN1895664A (en) Cordyceps sinensis and emu collagens peptide capsules and production thereof
CN101818100A (en) Preparation method of polybutylcyanoacrylate-encapsulated jasminum grandiflorum essence capsule
CN109350574A (en) A kind of compact maintenance frost of ight

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20191203

WW01 Invention patent application withdrawn after publication